DaRT seeds

DEVICE3 trials

Sponsors

Alpha Tau Medical LTD.

Conditions

Alpha RadiationBrachytherapyCarcinoma of the VulvaCarcinoma, SquamousImmunocompromisedRecurrent Carcinoma of the VulvaRecurrent Squamous Cell CarcinomaSkin Cancer

Unknown Phase

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma

Active, not recruitingNCT05323253

Alpha Tau Medical LTD.Recurrent Squamous Cell Carcinoma

Start: 2022-09-21End: 2027-04-01Target: 86Updated: 2026-06-16

Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).

Not yet recruitingNCT06202339

Alpha Tau Medical LTD.Carcinoma of the Vulva, Recurrent Carcinoma of the Vulva

Start: 2024-04-30End: 2026-12-31Target: 10Updated: 2024-01-31

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

RecruitingNCT06615635

Alpha Tau Medical LTD.Alpha Radiation, Brachytherapy, Carcinoma, Squamous +3

Start: 2026-01-01End: 2026-12-01Target: 28Updated: 2026-07-15

Related Papers

Extended Follow-Up Outcomes from Pooled Prospective Studies Evaluating Efficacy of Interstitial Alpha Radionuclide Treatment for Skin and Head and Neck Cancers

Cancers2024-06-2410 citations